Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication

Abstract

Normal human melanocytes are interspersed singly among keratinocytes along the basement membrane of the epidermis, whereas melanoma cells readily adhere to each other during invasion of the dermis or distant organs. The tumorigenic and metastatic phenotype of melanoma cells often correlates with increased expression of cell–cell and cell-matrix adhesion receptors. Mel-CAM (MCAM, MUC 18, CD146) is a cell–cell adhesion receptor highly expressed by melanoma cells but not normal melanocytes. We show here that inhibition of Mel-CAM expression in metastatic melanoma cells using genetic suppressor elements of Mel-CAM cDNA leads to inhibition of adhesion between melanoma cells and to downregulation of the tumorigenic phenotype. Growth was not inhibited in genetic suppressor elements-transduced melanoma cells cultured in monolayers but was inhibited when cells were maintained anchorage-independently in soft agar and greatly reduced in immunodeficient mice. A three-dimensional epidermal skin equivalent model demonstrated that Mel-CAM allows melanoma cells to separate from the epidermis and invade the basement membrane zone and dermis. However, melanoma cells with little or no Mel-CAM were poorly invasive, possibly due to their loss of gap junctional communication. These results suggest the multifunctional role of a melanoma-associated cell–cell adhesion receptor in tumor progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

CAM:

cellular adhesion molecule

GSE:

genetic suppressor element

PCR:

polymerase chain reaction

References

  • Anfosso F, Bardin N, Frances V, Vivier E, Camoin-Jau L, Sampol J, Dignat-George F . 1998 J. Biol. Chem. 273: 26852–26856

  • Bardin N, George F, Mutin M, Brisson C, Horschowski N, Frances V, Lesaule G, Sampol J . 1996 Tissue Antigens 48: 531–539

  • Bryant PJ . 1997 Dev. Genet. 20: 75–90

  • Cochlovius B, Zawadzki V, Perschl A, Zoller M . 1998 Adv. Exp. Med. Biol. 451: 345–348

  • Degen WG, van Kempen LC, Gijzen EG, van Groningen JJ, van Kooyk Y, Bloemers HP, Swart GW . 1998 Am. J. Pathol. 152: 805–813

  • Graham FL, Prevec L . 1995 Mol. Biotechnol. 3: 207–220

  • Gudkov AV, Kazarov AR, Thimmapaya R, Axenovich SA, Mazo IA, Roninson IB . 1994 Proc. Natl. Acad. Sci. USA 91: 3744–3748

  • Hannon GJ, Sun P, Carnero A, Xie LY, Maestro R, Conklin DS, Beach D . 1999 Science 283: 1129–1130

  • He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B . 1998 Proc. Natl. Acad. Sci. USA 95: 2509–2514

  • Herlyn D, Iliopoulos D, Jensen PJ, Parmiter A, Baird J, Hotta H, Adachi K, Ross AH, Jambrosic J, Koprowski H, Herlyn M . 1990 Cancer Res. 50: 2296–2302

  • Herlyn M . 1993 Molecular and Cellular Biology of Melanoma R.G. Landes Co., Austin pp 1–93

    Google Scholar 

  • Holness CL, Simmons DL . 1994 J. Cell Sci. 107: 2065–2070

  • Hsu M, Andl T, Li G, Meinkoth JL, Herlyn M . 2000 J. Cell Sci. 113: 1535–1542

  • Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, Elder DE, Herlyn M . 2000 Am. J. Pathol. 156: 1515–1525

  • Hsu MY, Shih DT, Meier FE, Van Belle P, Hsu JY, Elder DE, Buck CA, Herlyn M . 1998 Am. J. Pathol. 153: 1435–1442

  • Johnson JP . 1994 Invasion Metastasis 14: 123–130

  • Johnson JP . 1999 Cancer Metastasis Rev. 18: 345–357

  • Johnson JP, Bar-Eli M, Jansen B, Markhof E . 1997 Int. J. Cancer 73: 769–774

  • Johnson JP, Rummel MM, Rothbacher U, Sers C . 1996 Curr. Top. Microbiol. Immunol. 213: 95–105

  • Kath R, Jambrosic JA, Holland L, Rodeck U, Herlyn M . 1991 Cancer Res. 51: 2205–2211

  • Kraus A, Masat L, Johnson JP . 1997 Melanoma Res. 7: S75–S81

  • Krutovskikh V, Yamasaki H . 1997 Histol. Histopathol. 12: 761–768

  • Lehmann JM, Riethmuller G, Johnson JP . 1989 Proc. Natl. Acad. Sci. USA 86: 9891–9895

  • Levenson VV, Lausch E, Kirschling DJ, Broude EV, Davidovich IA, Libants S, Fedosova V, Roninson IB . 1999 Somat. Cell Mol. Genet. 25: 9–26

  • Li G, Herlyn M . 2000 Mol. Med. Today 6: 163–169

  • Lynch CM, Miller AD . 1991 J. Virol. 65: 3887–3890

  • Marcusson EG, Yacyshyn BR, Shanahan WR, Jr, Dean NM . 1999 Mol. Biotechnol. 12: 1–11

  • Meier F, Nesbit M, Hsu MY, Martin B, Van Belle P, Elder DE, Schaumburg-Lever G, Garbe C, Walz TM, Donatien P, Crombleholme TM, Herlyn M . 2000 Am. J. Pathol. 156: 193–200

  • Morgan RA, Couture L, Elroy-Stein O, Ragheb J, Moss B, Anderson WF . 1992 Nucleic Acids Res. 20: 1293–1299

  • Morimoto C, Tachibana K . 1996 Hum. Cell 9: 163–168

  • Naviany RK, Costanzi E, Haas M, Verna IM . 1996 J. Virol. 70: 5701–5705

  • Nesbit M, Herlyn M . 1994 Invasion Metastasis 14: 131–146

  • Pestov DG, Lau LF . 1994 Proc. Natl. Acad. Sci. USA 91: 12549–12553

  • Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Fae J, Waclavicek M, Stockl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W . 1997 J. Immunol. 158: 2107–2115

  • Roninson IB, Gudkov AV, Holzmayer TA, Kirschling DJ, Kazarov AR, Zelnick CR, Mazo IA, Axenovich S, Thimmapaya R . 1995 Cancer Res. 55: 4023–4028

  • Rummel MM, Sers C, Johnson JP . 1996 Cancer Res. 56: 2218–2223

  • Sambrook J, Maniatis T, Fritsch EF . 1989 Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA

    Google Scholar 

  • Satyamoorthy K, DeJesus E, Linnenbach AJ, Kraj B, Kornreich DL, Rendle S, Elder DE, Herlyn M . 1997 Melanoma Res. 7: S35–S42

  • Sers C, Riethmuller G, Johnson JP . 1994 Cancer Res. 54: 5689–5694

  • Shih IM . 1999 J. Pathol. 189: 4–11

  • Shih IM, Elder DE, Speicher D, Johnson JP, Herlyn M . 1994 Cancer Res. 54: 2514–2520

  • Shih IM, Speicher D, Hsu MY, Levine E, Herlyn M . 1997 Cancer Res. 57: 3835–3840

  • St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW . 2000 Science 289: 1197–1202

  • Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M . 1997 Cancer Res. 57: 2295–2303

  • Yagi T, Takeichi M . 2000 Genes Dev. 14: 1169–1180

  • Yamasaki H . 1996 Mutat. Res. 365: 91–105

Download references

Acknowledgements

We thank the members of the Editorial Department for their assistance. This work was supported in part by NIH grants CA47159, CA25874, CA76674, CA74294, DK50306, CA10815, and by NASA grant NAG9-832, and by funding from Mary AH Rumsey Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Meenhard Herlyn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Satyamoorthy, K., Muyrers, J., Meier, F. et al. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 20, 4676–4684 (2001). https://doi.org/10.1038/sj.onc.1204616

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204616

Keywords

This article is cited by

Search

Quick links